Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart
Author:
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.2006.01913.x/fullpdf
Reference19 articles.
1. Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.
2. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
3. 3S Ashwell, J Gebbie, and P. Home, Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times . Diabet Med2006 ; 23 : 46 -52 .
4. A Randomized Clinical Trial Comparing Breakfast, Dinner, or Bedtime Administration of Insulin Glargine in Patients With Type 1 Diabetes
5. The Effect of the Insulin Analog Lispro on Nighttime Blood Glucose Control in Type 1 Diabetic Patients
Cited by 99 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bridging dose of U‐100 glargine with first dose of insulin degludec improves glycaemia in the 48 h after transition in twice‐daily glargine users;Diabetes, Obesity and Metabolism;2024-02-28
2. Current usage of long-acting insulin analogs in patients with type 2 diabetes mellitus;Expert Review of Endocrinology & Metabolism;2024-02-20
3. Nuevas Insulinas en el tratamiento de la Diabetes Tipo 1;Andes Pediatrica;2023-06-15
4. The Effect of BMI on Pharmacokinetic and Pharmacodynamic Parameters of Insulin Degludec: Results from an Euglycemic Glucose Clamp Study;Clinical Pharmacokinetics;2023-02-04
5. Once-weekly basal insulin icodec: Looking ONWARDS from pharmacology to clinical trials;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3